Related references
Note: Only part of the references are listed.Adiponectin levels in patients with colorectal cancer and adenoma: a meta-analysis
Wei An et al.
EUROPEAN JOURNAL OF CANCER PREVENTION (2012)
Meta-analysis: Circulating adiponectin levels and risk of colorectal cancer and adenoma
Xi Tao Xu et al.
JOURNAL OF DIGESTIVE DISEASES (2011)
Interaction between Adiponectin and Leptin Influences the Risk of Colorectal Adenoma
Taiki Yamaji et al.
CANCER RESEARCH (2010)
Adiponectin Represses Colon Cancer Cell Proliferation via AdipoR1-and-R2-Mediated AMPK Activation
A. Young Kim et al.
MOLECULAR ENDOCRINOLOGY (2010)
Decreased levels of plasma adiponectin associated with increased risk of colorectal cancer
Sayaka Otake et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2010)
Association of Visceral Fat Accumulation and Adiponectin Levels with Colorectal Neoplasia
Elife Erarslan et al.
DIGESTIVE DISEASES AND SCIENCES (2009)
Elevated circulating adiponectin and elevated insulin sensitivity in adiponectin transgenic mice are not associated with reduced susceptibility to colon carcinogenesis
Kafi N. Ealey et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
Serum leptin, adiponectin, and resistin concentration in colorectal adenoma and carcinoma (CC) patients
Anna Kumor et al.
INTERNATIONAL JOURNAL OF COLORECTAL DISEASE (2009)
Adiponectin and colorectal adenomas: Self defense forces health study
Jin Fukumoto et al.
CANCER SCIENCE (2008)
Adiponectin suppresses colorectal carcinogenesis under the high-fat diet condition
T. Fujisawa et al.
GUT (2008)
Components of the metabolic syndrome and colorectal cancer risk; a prospective study
T. Stocks et al.
INTERNATIONAL JOURNAL OF OBESITY (2008)
Pathophysiological significance of adiponectin
Makoto Nishida et al.
MEDICAL MOLECULAR MORPHOLOGY (2007)
Plasma C-peptide, insulin-like growth factor-I, insulin-like growth factor binding proteins and risk of colorectal cancer in a nested case-control study: The Japan public health center-based prospective study
Tetsuya Otani et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
Low plasma adiponectin levels and risk of colorectal cancer in men: A prospective study
EK Wei et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2005)
Changing patterns of colorectal cancer in China over a period of 20 years
Ming Li et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2005)
A prospective study of C-peptide, insulin-like growth factor-1, insulin-like growth factor binding protein-1, and the risk of colorectal cancer in women
EK Wei et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2005)
A prospective study of plasma C-peptide and colorectal cancer risk in men
J Ma et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2004)
Adiponectin-induced antiangiogenesis and antitumor activity involve caspase-mediated endothelial cell apoptosis
E Bråkenhielm et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Overweight, obesity and cancer: Epidemiological evidence and proposed mechanisms
EE Calle et al.
NATURE REVIEWS CANCER (2004)
Circulating adiponectin and resistin levels in relation to metabolic factors, inflammatory markers, and vascular reactivity in diabetic patients and subjects at risk for diabetes
GK Shetty et al.
DIABETES CARE (2004)
Regulation of adipocytokines and insulin resistance
M Fasshauer et al.
DIABETOLOGIA (2003)
Association between adiponectin and mediators of inflammation in obese women
S Engeli et al.
DIABETES (2003)
The role of the novel adipocyte-derived hormone adiponectin in human disease
JJ Díez et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2003)
Plasma adiponectin concentrations predict insulin sensitivity of both glucose and lipid metabolism
O Tschritter et al.
DIABETES (2003)
Share Paper
